PCCTech Minutes 2012 07 18: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
* Other changes to options and groupings reviewed and polished. | * Other changes to options and groupings reviewed and polished. | ||
* Discussion on security/policy content in the profile vs XDW profile and other technical framework areas held. Determined regereces will be made - but specific details avoided in the workflow profiles due to the large variation in security policies worldwide. | * Discussion on security/policy content in the profile vs XDW profile and other technical framework areas held. Determined regereces will be made - but specific details avoided in the workflow profiles due to the large variation in security policies worldwide. | ||
===Tumor Board=== | |||
* Reviewed all changes made to date. Outstanding issues are to get the diagrams into UML form and to resolve the status issues discussed earlier. (Planned for joint meeting this afternoon). | |||
* | |||
Revision as of 11:40, 18 July 2012
Attendees: Laura Heermann Langford, Laura Bright, Anne Diamond, Vincent Van Pelt, Saccavini Claudio, Mauro Zanardini, Emma Jones, Denise Downing, Thom Kuhn, David Stumpf,
Call in Attendees: Valentina Ferrarini,
Tele Home Health Monitoring
- Discussion of statuses and the concept of "failed". Currently requirements of failed is for that task to be completed. In out clinical use cases sometimes there is a need to continue the task regardless of the failure and need to got through more statuses. question if we need to establish a second task and link them, or if we can have some flexibility with the statuses. Decision postponed until after discussion with ITI this afternoon.
- Reviewed additional text to the use case. Agreed that it is improving the document but needs a little more clinical detail added. Vincent will assist the team with clinical details.
eReferral
- Issue regarding clarity with "actors" resolved by removing the term "actors" from the document and inserting "participants" and "user".
- Clinical story added to use case section. Some discussion to clarify the story and assure it aligns with the use case diagram.
- Other changes to options and groupings reviewed and polished.
- Discussion on security/policy content in the profile vs XDW profile and other technical framework areas held. Determined regereces will be made - but specific details avoided in the workflow profiles due to the large variation in security policies worldwide.
Tumor Board
- Reviewed all changes made to date. Outstanding issues are to get the diagrams into UML form and to resolve the status issues discussed earlier. (Planned for joint meeting this afternoon).